Top
Topic: Long Noncoding RNAs in Cancer Metastasis

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 31 Dec 2020

Guest Editor(s)

  • Prof. Brian D. Adams
    Department of RNA Science at The Brain Institute of America, New Haven, USA.

    Website

  • Prof. Kazunari K. Yokoyama
    Graduate Institute of Medicine, Center of Excellence for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

    Website | E-mail

Special Issue Introduction

The discovery that non-coding RNA genes are responsible for maintaining a key regulatory balance within animal cells that in turn prevents the onset of tumorigenesis and metastatic progression has been one of the largest scientific breakthroughs within the field of biological sciences. Specifically, long-noncoding RNA (lncRNAs) are epigenetic regulators that dampen stochastic gene expression, recruit specific chromatin modifiers to particular genomic loci, and communicate with other non-coding RNAs that result in the modulation of transcriptional and post-transcriptional processes that promotes the maintenance of chromatin integrity.
Specifically, lcRNAs are a divergent class of ncRNA molecule greater than 200 nt in length that lack protein-coding capacity, and initially considered a genetic byproduct because of the absence of biological function. However, when lncRNAs are aberrantly expressed the checkpoints that maintain cellular growth and differentiation processes fail, supporting a process known as epithelial to mesenchymal transition (EMT).
EMT, is the transformative process by which cells loose epithelial polarity and become motile, thereby enabling epithelial cells to transit to a mesenchymal phenotype, to intravasate into vascular systems, and extravasate to distant organ sites. Given EMT is the rate limiting step at which a tumor cell becomes metastatic, resulting in fatality, many investigators have dedicated their efforts in understanding the cell signaling cues that initiate and support EMT.
Recently, a number of studies have identified lncRNAs that control the cellular processes related to EMT, and moreover modulate the phenotypic observation of metastatic dissemination in vivo. Therefore, this special issue focuses on studies that showcase how certain lncRNAs can modulate or disrupt the initiating processes of metastasis (i.e., modulate epithelial cell polarity, anchorage-independent growth, wound healing, migration, and invasion). By elucidating how these lncRNAs control the biological processes supporting metastatic progression therapies that target this process can be develop in order to reduce tumor-related deaths associated with aggressive carcinomas.

Keywords

lncRNA, long noncoding RNA, metastasis (cell polarity, anchorage-independent growth, wound healing, migration, and invasion), noncoding RNA, cancer, epithelial-mesenchymal transition, mesenchymal-epithelial transition, chromatin regulation, de-differentiation, epigenetic control, malignancy, precancerous state

Submission Deadline

31 Dec 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://jcmtjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/jcmt
Submission Deadline: 31 Dec 2020
Contacts: Monica Gao, Assistant Editor, monica@jcmtjournal.com

Published Articles

This special issue is now open for submission.